Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
3 clinical trials · Condition
◉ Watch Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
| Record | Firm | Date |
|---|---|---|
| SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 (NCT05629962) | Atea Pharmaceuticals, Inc. | 2022-11-25 |
| A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients (NCT04847141) | Grifols Therapeutics LLC | 2021-04-28 |
| Antibodies Responses to COVID-19 Infection in Hospitalized Patients (NCT04520880) | Imam Abdulrahman Bin Faisal University | 2020-08-01 |
Track Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection) automatically
Every clearance here is in the API, with alerts when new ones post.